JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dukes, I. D.
Right arrow Articles by Morad, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dukes, I. D.
Right arrow Articles by Morad, M.

Tedisamil blocks the transient and delayed rectifier K+ currents in mammalian cardiac and glial cells

ID Dukes, L Cleemann and M Morad

Department of Physiology, University of Pennsylvania, Philadelphia.

The potassium currents in rat and guinea pig ventricular myocytes and mouse astrocytes were studied using tedisamil, a novel antiarrhythmic agent. A 1 to 20 microM dosage of tedisamil caused marked prolongation of the action potential in isolated rat ventricular myocytes, mimicking its reported effects on multicellular rat heart preparations. Under voltage clamp conditions, tedisamil caused a dose-dependent increase in the speed of inactivation of the transient outward K+ current (Ito), the predominant outward current in rat ventricular myocytes. In cardiac myocytes, the tedisamil block was neither use- nor voltage-dependent. The slow reversibility of drug action when applied from the outside, and its effectiveness when applied intracellularly, suggested an internal site of drug action. In guinea pig ventricular myocytes, tedisamil blocked the slowly developing time-dependent delayed rectifier K+ current (IK) over the same concentration range as that found for Ito in the rat myocytes. Tedisamil reduced this current without changing the characteristics of its slow (tau approximately 1 sec) activation. The effects of tedisamil on Ito and IK were independent of the phosphorylation state of the channel, as assessed by the equal effectiveness of the drug in the presence or absence of isoproterenol. Tedisamil also blocked the transient K+ current and the delayed rectifier current (IK) in mouse astrocytes over the same concentration range as that found in the cardiac myocytes and by a process that accelerated (transient K+ current) or mimicked (IK) inactivation. At concentrations of up to 50 microM, tedisamil had little effect on the time-dependent inward rectifier K+ current, or inward calcium current in rat or guinea pig ventricular myocytes.(ABSTRACT TRUNCATED AT 250 WORDS)

Volume 254, Issue 2, pp. 560-569, 08/01/1990
Copyright © 1990 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
Eur Heart J SupplHome page
B. N. Singh and E. Aliot
Newer antiarrhythmic agents for maintaining sinus rhythm in atrial fibrillation: simplicity or complexity?
Eur. Heart J. Suppl., September 1, 2007; 9(suppl_G): G17 - G25.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. A. Jacobson, C. R. Weber, S. Bao, J. Turk, and L. H. Philipson
Modulation of the Pancreatic Islet beta-Cell-delayed Rectifier Potassium Channel Kv2.1 by the Polyunsaturated Fatty Acid Arachidonate
J. Biol. Chem., March 9, 2007; 282(10): 7442 - 7449.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. R. Ehrlich, C. Hoche, P. Coutu, C. Metz-Weidmann, W. Dittrich, S. H. Hohnloser, S. Nattel, and H. Gogelein
Properties of a Time-Dependent Potassium Current in Pig Atrium: Evidence for a Role of Kv1.5 in Repolarization
J. Pharmacol. Exp. Ther., November 1, 2006; 319(2): 898 - 906.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
A. Royer, S. Demolombe, A. El Harchi, K. Le Quang, J. Piron, G. Toumaniantz, D. Mazurais, C. Bellocq, G. Lande, C. Terrenoire, et al.
Expression of human ERG K+ channels in the mouse heart exerts anti-arrhythmic activity
Cardiovasc Res, January 1, 2005; 65(1): 128 - 137.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. Tamargo, R. Caballero, R. Gomez, C. Valenzuela, and E. Delpon
Pharmacology of cardiac potassium channels
Cardiovasc Res, April 1, 2004; 62(1): 9 - 33.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
P. Dorian
Antiarrhythmic Drug Therapy of Atrial Fibrillation: Focus on New Agents
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2003; 8(1_suppl): S27 - S31.
[Abstract] [PDF]


Home page
Circ. Res.Home page
S. L. Bouter, S. Demolombe, A. Chambellan, C. Bellocq, F. Aimond, G. Toumaniantz, G. Lande, S. Siavoshian, I. Baro, A. L. Pond, et al.
Microarray Analysis Reveals Complex Remodeling of Cardiac Ion Channel Expression With Altered Thyroid Status: Relation to Cellular and Integrated Electrophysiology
Circ. Res., February 7, 2003; 92(2): 234 - 242.
[Abstract] [Full Text] [PDF]


Home page
J Biomol ScreenHome page
K. Schroeder, B. Neagle, D. J. Trezise, and J. Worley
IonworksTM Ht: A New High-Throughput Electrophysiology Measurement Platform
J Biomol Screen, February 1, 2003; 8(1): 50 - 64.
[Abstract] [PDF]


Home page
Toxicol PatholHome page
M. R. Gralinski
The Dog's Role in the Preclinical Assessment of QT Interval Prolongation
Toxicol Pathol, January 1, 2003; 31(1_suppl): 11 - 16.
[Abstract] [PDF]


Home page
J. Appl. Physiol.Home page
S.-S. Zhou, Z. Gao, L. Dong, Y.-F. Ding, X.-D. Zhang, Y.-M. Wang, J.-M. Pei, F. Gao, and X.-L. Ma
Anion channels influence ECC by modulating L-type Ca2+ channel in ventricular myocytes
J Appl Physiol, November 1, 2002; 93(5): 1660 - 1668.
[Abstract] [Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
S. A. Doggrell and V. Nand
Effects of Tedisamil on Cardiovascular Tissues Isolated from Normoand Hypertensive Rats
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2001; 6(3): 261 - 272.
[Abstract] [PDF]


Home page
Cardiovasc ResHome page
G. Lande, S. Demolombe, A. Bammert, A. Moorman, F. Charpentier, and D. Escande
Transgenic mice overexpressing human KvLQT1 dominant-negative isoform Part II: Pharmacological profile
Cardiovasc Res, May 1, 2001; 50(2): 328 - 334.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
T.G Hammond, L Carlsson, A.S Davis, W.G Lynch, I MacKenzie, W.S Redfern, A.T Sullivan, and A.J Camm
Methods of collecting and evaluating non-clinical cardiac electrophysiology data in the pharmaceutical industry: results of an international survey
Cardiovasc Res, March 1, 2001; 49(4): 741 - 750.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
H. Wang, H. Shi, L. Zhang, M. Pourrier, B. Yang, S. Nattel, and Z. Wang
Nicotine Is a Potent Blocker of the Cardiac A-Type K+ Channels : Effects on Cloned Kv4.3 Channels and Native Transient Outward Current
Circulation, September 5, 2000; 102(10): 1165 - 1171.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. S. Lader, Y.-F. Xiao, C. R. O'Riordan, A. G. Prat, G. R. Jackson Jr., and H. F. Cantiello
cAMP activates an ATP-permeable pathway in neonatal rat cardiac myocytes
Am J Physiol Cell Physiol, July 1, 2000; 279(1): C173 - C187.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
K M Fox, J R Henderson, J C Kaski, A Sachse, L Kuester, and S Wonnacott
Antianginal and anti-ischaemic efficacy of tedisamil, a potassium channel blocker
Heart, February 1, 2000; 83(2): 167 - 171.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Cell Physiol.Home page
A. S. Lader, Y. Wang, G. R. Jackson Jr., S. C. Borkan, and H. F. Cantiello
cAMP-activated anion conductance is associated with expression of CFTR in neonatal mouse cardiac myocytes
Am J Physiol Cell Physiol, February 1, 2000; 278(2): C436 - C450.
[Abstract] [Full Text] [PDF]


Home page
Physiol. Rev.Home page
J. R. Hume, D. Duan, M. L. Collier, J. Yamazaki, and B. Horowitz
Anion Transport in Heart
Physiol Rev, January 1, 2000; 80(1): 31 - 81.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. A. Sanchez-Chapula
Mechanism of Transient Outward K+ Channel Block by Disopyramide
J. Pharmacol. Exp. Ther., August 1, 1999; 290(2): 515 - 523.
[Abstract] [Full Text]


Home page
Cardiovasc ResHome page
S. Sorota
Insights into the structure, distribution and function of the cardiac chloride channels
Cardiovasc Res, May 1, 1999; 42(2): 361 - 376.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Z. Wang, J. Feng, H. Shi, A. Pond, J. M. Nerbonne, and S. Nattel
Potential Molecular Basis of Different Physiological Properties of the Transient Outward K+ Current in Rabbit and Human Atrial Myocytes
Circ. Res., March 19, 1999; 84(5): 551 - 561.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
E. P. Baskin and J. J. Lynch Jr.
Differential Atrial versus Ventricular Activities of Class III Potassium Channel Blockers
J. Pharmacol. Exp. Ther., April 1, 1998; 285(1): 135 - 142.
[Abstract] [Full Text]


Home page
CirculationHome page
P. Bailly, J.-P. Benitah, M. Mouchoniere, G. Vassort, and P. Lorente
Regional Alteration of the Transient Outward Current in Human Left Ventricular Septum During Compensated Hypertrophy
Circulation, August 19, 1997; 96(4): 1266 - 1274.
[Abstract] [Full Text]


Home page
J CARDIOVASC PHARMACOL THERHome page
B. N. Singh
Searching for the Ideal Class III Antiarrhythmic Agent: How Pure Should They Be?
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(4): 239 - 242.
[PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
M. Nemeth, A. Varro, L. Virag, O. Hala, D. Thormahlen, and J. Gyula Papp
Frequency-dependent Cardiac Electrophysiologic Effects of Tedisamil: Comparison With Quinidine and Sotalol
Journal of Cardiovascular Pharmacology and Therapeutics, January 1, 1997; 2(4): 273 - 284.
[Abstract] [PDF]


Home page
CirculationHome page
N. K. Jurkiewicz, J. Wang, B. Fermini, M. C. Sanguinetti, and J. J. Salata
Mechanism of Action Potential Prolongation by RP 58866 and Its Active Enantiomer, Terikalant: Block of the Rapidly Activating Delayed Rectifier K+ Current, IKr
Circulation, December 1, 1996; 94(11): 2938 - 2946.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
A. F. James, T. Tominaga, Y. Okada, and M. Tominaga
Distribution of cAMP-Activated Chloride Current and CFTR mRNA in the Guinea Pig Heart
Circ. Res., August 1, 1996; 79(2): 201 - 207.
[Abstract] [Full Text]


Home page
Circ. Res.Home page
M. C. Oz and S. Sorota
Forskolin Stimulates Swelling-Induced Chloride Current, Not Cardiac Cystic Fibrosis Transmembrane-Conductance Regulator Current, in Human Cardiac Myocytes
Circ. Res., June 1, 1995; 76(6): 1063 - 1070.
[Abstract] [Full Text]


Home page
CirculationHome page
K. Mori, Y. Hara, T. Saito, Y. Masuda, and H. Nakaya
Anticholinergic Effects of Class III Antiarrhythmic Drugs in Guinea Pig Atrial Cells : Different Molecular Mechanisms
Circulation, June 1, 1995; 91(11): 2834 - 2843.
[Abstract] [Full Text]


Home page
CirculationHome page
C. I. Berul and M. Morad
Regulation of Potassium Channels by Nonsedating Antihistamines
Circulation, April 15, 1995; 91(8): 2220 - 2225.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1990 by the American Society for Pharmacology and Experimental Therapeutics.